Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?

• Autores principales: Farzad Khademi (Autor), Mohammad Derakhshan (Autor), Arshid Yousefi-Avarvand (Autor), Mohsen Tafaghodi (Autor), Saman Soleimanpour (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Introduction: More than two billion people are latently infected with Mycobacterium tuberculosis. Most tuberculosis (TB)-subunit vaccines currently in various stages of clinical trials are designed for prevention of active TB, but not to prevent reactivation of latent TB-infection. Thus, there is an...